AXGN Research and Charts

AXGN - Axogen Inc (Healthcare: Medical Devices)

Projected Earnings Date: 2019-11-04 (Delayed quote data 2026-02-10)

Last 34.51	Change ⇑ +0.58 (+1.71%)	Volume 414,400
	Open 34.05	High 34.90	Low 33.59

8EMA (Daily) 34.33	40EMA (Daily) 32.21	50EMA (Daily) 31.37	STO (Daily) 65.946	MACD Hist (Daily) -0.107
8EMA (Weekly) 32.963	40EMA (Weekly) 23.79	50EMA (Weekly) 22.26	STO (Weekly) 89.596	MACD Hist (Weekly) -0.166


Company Profile
Axogen Inc is engaged in the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically proven and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, United Kingdom, Spain, South Korea, and several other countries.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.